Literature DB >> 20701722

Exercise in end-stage renal disease.

Eva Segura-Orti1, Kirsten L Johansen.   

Abstract

This article will outline the clinical reasoning for exercise counseling in end-stage renal disease (ESRD) patients and give healthcare providers detailed information on the different programs that can be implemented in this population according to patients' specific needs. End-stage renal disease patients often have other health problems that can be improved by participation in regular exercise programs. Research accumulated during the last 30 years on exercise for the ESRD population supports its numerous beneficial effects including those on cardiovascular capacity, sarcopenia, and health-related quality of life. We describe the different types of exercise, aerobic and resistance programs (including their frequency, intensity and progression) that are recommended for the ESRD population, as well as the potential goals of each program. Groups with special needs among the ESRD population are considered, as well as safety, potential adverse events, and adherence to exercise programs. Finally, recommendations for future researches are highlighted.

Entities:  

Mesh:

Year:  2010        PMID: 20701722     DOI: 10.1111/j.1525-139X.2010.00766.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  14 in total

1.  Impact of home-based aerobic exercise on the physical capacity of overweight patients with chronic kidney disease.

Authors:  Danilo Takashi Aoike; Flavia Baria; Maria Ayako Kamimura; Adriano Ammirati; Marco Túlio de Mello; Lilian Cuppari
Journal:  Int Urol Nephrol       Date:  2014-12-11       Impact factor: 2.370

Review 2.  Prehabilitation for the Frail Patient Approaching ESRD.

Authors:  Anoop Sheshadri; Kirsten L Johansen
Journal:  Semin Nephrol       Date:  2017-03       Impact factor: 5.299

3.  Physical Activity in the Prevention of Chronic Kidney Disease.

Authors:  Craig S Stump
Journal:  Cardiorenal Med       Date:  2011-07-25       Impact factor: 2.041

4.  Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease.

Authors:  Danilo Takashi Aoike; Flavia Baria; Maria Ayako Kamimura; Adriano Ammirati; Lilian Cuppari
Journal:  Clin Exp Nephrol       Date:  2017-06-22       Impact factor: 2.801

5.  Impact of an intradialysis virtual-reality-based exercise program on healthcare resources expenditure: a micro-costing analysis.

Authors:  Alicia García-Testal; Francisco José Martínez-Olmos; Jose Antonio Gil-Gómez; Javier Villalón-Coca; Rafael Ortiz-Ramón; Alicia Cana-Poyatos; Rafael García-Maset; Eva Segura-Ortí
Journal:  BMC Nephrol       Date:  2022-06-27       Impact factor: 2.585

6.  Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis.

Authors:  Eva Román; Maria Teresa Torrades; Maria Josep Nadal; Guillem Cárdenas; Juan Camilo Nieto; Sílvia Vidal; Helena Bascuñana; Cándido Juárez; Carlos Guarner; Juan Córdoba; Germán Soriano
Journal:  Dig Dis Sci       Date:  2014-03-06       Impact factor: 3.199

Review 7.  Exercise training in chronic kidney disease patients.

Authors:  Erin J Howden; Robert G Fassett; Nicole M Isbel; Jeff S Coombes
Journal:  Sports Med       Date:  2012-06-01       Impact factor: 11.136

8.  Dog walk: a simple way to improve chronic kidney disease patients' inactivity.

Authors:  Denise Mafra; Denis Fouque
Journal:  NDT Plus       Date:  2011-10

9.  Does swimming exercise affect experimental chronic kidney disease in rats treated with gum acacia?

Authors:  Badreldin H Ali; Suhail Al-Salam; Mohammed Al Za'abi; Khalid A Al Balushi; Aishwarya Ramkumar; Mostafa I Waly; Javid Yasin; Sirin A Adham; Abderrahim Nemmar
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

10.  Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial.

Authors:  Eva Román; Cristina García-Galcerán; Teresa Torrades; Silvia Herrera; Ana Marín; Maite Doñate; Edilmar Alvarado-Tapias; Jorge Malouf; Laura Nácher; Ricard Serra-Grima; Carlos Guarner; Juan Cordoba; German Soriano
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.